Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)

Slides:



Advertisements
Similar presentations
EUROCHIP-3 WORK PACKAGES. MAIN WORK PACKAGES of EUROCHIP-3 Ahti Anttila Adherence to cervical screening in 5 Eastern EU countries Renée Otter Population-based.
Advertisements

EUROCHIP-3: WP-4 Publications Paolo Baili Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
High Resolution data for rare cancers Annalisa Trama Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy ) WORKSHOP FOR A EUROPEAN HIGH RESOLUTION.
MUNROS is funded by the European Commission FP7 programme MUNROS is funded by the European Commission FP7 programme,
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
Quality Label and Certification Processes Vienna Summit 11 April 2014 Karima Bourquard Director of Interoperability IHE-Europe.
Public Health Programme EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROCHIP-3 WP-4 Update EUROCHIP: EUROpean Cancer Health Indicator.
Quality dimensions in health policy state of the art & visions of the future Marek Haber Deputy Minister of Health.
European Partnership for Action Against Cancer (EPAAC)
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
Health & Consumer Protection Directorate General EU Public Health Programme and action on rare diseases John F Ryan Head of Unit European Commission.
Name Speaker This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding from the European.
This document arises from the project InNerMeD-I-Network which has received funding from the European Union, in the framework of the Health Programme INHERITED.
Work Package 7 Information for patients with rare cancers WP leader: Francesco De Lorenzo.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
High Resolution Studies within the European Cancer Information System Cooperation with EPAAC Riccardo Capocaccia Istituto Superiore di Sanità (ISS), Italy.
Health Promoting Health Service: Development day.
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
Analysis, modelling and sensing of both physiological and environmental factors for the customized and predictive self-management of Asthma H2020-PHC-2014-single-stage.
Work Package 5 Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
Work Package 2 Dissemination of the project RARECARENet Aidan Hutchison on behalf of Professor Ian Kunkler University of Edinburgh.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
Information network on rare cancers INFORMATION NETWORK ON RARE CANCERS (RARECARENet) Kick-off meeting - Friday, July Gemma Gatta Fondazione IRCCS,
Work Package 5 Objectives of the work shop Utrecht 17 th January 2014 Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
European Union Network for Patient Safety and Quality of Care BMJ Forum. Paris. April 10, 2014 Good Organisational Practices for Exchange Mechanism Work.
EUROCHIP-2 EUROCHIP-2 - The Action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
The impact on practice, costs and outcomes of New Roles for health professionals in Europe (MUNROS) Antoinette de Bont/ associate professor/ Erasmus University.
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Information network on rare cancers Work Package 4 Information on epidemiology of rare cancers Riccardo Capocaccia and Sandra Mallone Cancer Epidemiology.
1 TOWARDS QUALITY, COMPREHENSIVENESS AND EXCELLENCE: THE ACCREDITATION PROGRAMME OF THE OECI FOR CANCER INSTITUTES Dr. Mahasti Saghatchian Chairwoman OECI.
EUROCHIP-Italia in EUROCHIP-2 Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
21 November 2013 Brussels Cristina Padeanu -PATIENT EVIDENCE WORKSHOP - JOINT ACTION ON PATIENT SAFETY AND QUALITY OF HEALTH CARE (PASQ) PROJECT.
RARE BEST PRACTICES COURSE ROMA (Feb ) Euro-HSP Madrid 2015 May 30 Jean Bénard May 31, GA 2015 Madrid.
Joint Action on Addressing Chronic Diseases and Healthy Ageing Across the Life-Cycle (JA-CHRODIS) An Overview Teresa Chavarría National Institute of Health.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
An initiative of the International Rare Diseases Research Consortium-IRDiRC Spanish Rare Diseases Registries Research Network – SpainRDR. Inventory of.
Public Health Research including Health Services Research BIOMED II Area 6 Professors Ingrid Mur-Veeman and Charles Wolfe.
Slide 1DSS Board 1-2 December 2014 Eurostat ESS.VIP ADMIN project on use of administrative data sources Agenda point 7 DSS Board 1-2 December 2014.
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
The Linneaus implementation in Greece Yannis Skalkidis MD, PhD, MPH, FACS Athens University Medical School ΕΘΝΙΚΟ & ΚΑΠΟΔΙΣΤΡΙΑΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ NATIONAL.
Aim: Describe how new health care professionals are deployed
EULAR Study Group on Systemic Lupus Erythematosus (SLE) Dimitrios T
2nd Bench – Can Core Group Meeting Welcome and introduction
WORK PROGRAMME to support the implementation of the Recommendation
Musculoskeletal Health in Europe
WP 4 – EPIDEMIOLOGY GEMMA Gatta
JARC – Work Package 5 Assuring Quality of Care 12 month Report
Institut de cancérologie Gustave Roussy
PROGRESS AND CHANGES IN
“2nd World Congress on Rare Diseases and Orphan Drugs”
Brussels, 15 September 2009.
HPH Strategy Seminar Beijing, China 7 september 2013 Andrea Limbourg
National Workshop on Rare Disease Centres of Reference
Working Package 7 (WP7) Health Care
JARC General Assembly, Oct 16th, 2017
STEERING COMMITTEE MEETING
Regional Oncology Social Work
Mark your diary: JARC deadlines and meeting
WP2 Dissemination The dissemination process will mainly be based on 2 specific objectives: 1. Information delivery on the JARC 2. Dissemination of the.
General Assembly, 26th October, 2018, Milan
Josep M. Borras Milano, October 25, 2018
Presentation transcript:

Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)

Information network on rare cancers What kind of information Who should be involved in the network How can we reach the community at large? Presentation topics

Information network on rare cancers Objectives/information on rare cancers To collect and disseminate information on updated epidemiological indicators and on health care pathways for rare cancers and on. To identify the qualification criteria for centers of expertise for rare cancers To produce and disseminate information on diagnosis and management of rare cancers. To develop a clinical database on very rare cancers to provide new knowledge on these diseases and on their clinical management To identify and disseminate information on centers of expertise for rare cancers. To develop and disseminate information for patients

Information network on rare cancers Objectives/information on rare cancers To collect and disseminate information on updated epidemiological indicators and on health care pathways for rare cancers and on. To identify the qualification criteria for centers of expertise for rare cancers To produce and disseminate information on diagnosis and management of rare cancers. To develop a clinical database on very rare cancers to provide new knowledge on these diseases and on their clinical management To identify and disseminate information on centers of expertise for rare cancers. To develop and disseminate information for patients WP4 WP5 WP6 WP7

Information network on rare cancers Work packages WP No/leaderWP name 1/G.GattaCoordination 2/I. KunklerDissemination 3/E. BenhamouEvaluation 4/R. CapocacciaInformation on epidemiology of rare cancers 5/S. SieslingInformation on centres of expertise for rare cancers 6/L. LicitraInformation on clinical management of rare cancers 7/F. De Lorenzo- J. Pelouchová Information for patients with rare cancers

Information network on rare cancers Information on epidemiology (1) EUROCARE cancer registries 22 european countries

Information network on rare cancers Information on epidemiology (2) Description of the health care pathway of rare cancers Analysis on the association between outcome and hospital case volumes High resolution study with a selected group of cancer registries

Information network on rare cancers Information on centres of expertise for rare cancers Identification of qualification criteria for centers of expertise for rare cancers Consensus meeting Pilot study for a subgroup of rare cancers in collaboration with selected cancer registries EUCERD Recommendations on Quality Criteria for Centres of Expertise for Rare Diseases in Member States

Information network on rare cancers information on diagnosis and management (1)

Information network on rare cancers information on diagnosis and management : VERY RARE CANCERS

Information network on rare cancers Information for patients with rare cancers … we have a lot of expectations List of patients associations dedicated to rare cancers List of centres of expertise for rare cancers Information materials on rare cancers

Information network on rare cancers Patient’s engagement Involvement of ECPC in all the different steps of the project ECPC speaking with one voice on behalf of all patients associations dedicated to rare cancers ensuring: – Provision of information about the project and its progresses to all members interested in rare cancers – Involvement of patients associations in specific tasks of the project – Development of a knowledge system – Empowerment of patients and of rare cancers avocates

Information network on rare cancers Who should be involved in the network?

Information network on rare cancers

Mapping of national cancer plans (EPAAC WP10) and national rare disease plans (in Europlan) Harmonisation of stakeholder views on rare disease/cancer policy Alignment of criteria for accreditation of centres of excellence, and criteria for ERN Harmonization of framework for Clinical Guidelines Bridging EU pre- marketing authorization and MS-level post- market authorization Alignment on methodologies for disease registries Evaluate ongoing EU initiatives on cancer/RD on health equity impact Suggested: Joining forces between EUCERD and EPAAC !

Information network on rare cancers

How can we reach the community at large?

Information network on rare cancers Orphanet, RCE EUCERD, EPAAC ECPC (FACE) START, Organisation of European Cancer Institutes (OECI) Scientific societies (ESMO, ESSO, ESTRO…) European School of Oncology (ESO) National and European celebretion The web-site More from WP2 presentation

Information network on rare cancers Thank you for your attention